Annual EBITDA
$1.45B$60.72M+4.38%
Summary
- Current Value
- As of today, JAZZ annual EBITDA is $1.45B, up +4.38% on
- Historical Performance
- JAZZ annual EBITDA is up +7.24% over the past 3 years, up +38.68% over the past 5 years
- All-Time High Comparison
- JAZZ annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- JAZZ annual EBITDA is +11.51% above its 3-year low of $1.30B reached on
- Sector Comparison
- JAZZ annual EBITDA is higher than 94.18% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.45B | +4.4% | +7.2% | +38.7% | +2076.6% | |
| Quarterly EBITDA | $504.30M | +28.3% | +59.0% | +143.4% | +1307.7% | |
| TTM EBITDA | $1.67B | +30.0% | +43.8% | +67.1% | +1501.6% | |
| Price | $244.96 | +110.0% | +75.0% | +72.3% | +514.5% | |
| PE Ratio | 16.89 | – | – | -88.8% | -9.7% | |
| Annual Revenue | $4.27B | +4.9% | +16.6% | +80.6% | +2355.7% | |
| Annual EPS | -$5.84 | -167.5% | -63.0% | -238.3% | -803.6% | |
| $751.12M | +3.4% | +4.3% | -1.9% | +1199.8% | ||
| Annual Net Income | -$356.15M | -163.6% | -59.0% | -249.3% | -1186.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.45B | at high | |
| 5Y | $1.45B | at high | |
| All | $1.45B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.30B | +11.5% | |
| 5Y | $951.76M | +52.1% | |
| All | -$122.08M | +1285.7% |
EBITDA History
FAQ
- What is the current annual EBITDA of JAZZ?
- As of today, JAZZ annual EBITDA is $1.45B
- What is 1-year change in JAZZ annual EBITDA?
- JAZZ annual EBITDA is up +4.38% year-over-year
- What is 3-year change in JAZZ annual EBITDA?
- JAZZ annual EBITDA is up +7.24% over the past 3 years
- How far is JAZZ annual EBITDA from its all-time high?
- JAZZ annual EBITDA is currently at its all-time high
- How does JAZZ annual EBITDA rank versus sector peers?
- JAZZ annual EBITDA is higher than 94.18% of companies in Healthcare sector
- When is JAZZ next annual earnings release?
- As of today, the next annual earnings release for JAZZ has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$504.30M$109.10M+27.61%
Summary
- Current Value
- As of today, JAZZ quarterly EBITDA is $504.30M, up +27.61% on
- Historical Performance
- JAZZ quarterly EBITDA is up +28.33% year-over-year, up +58.98% over the past 3 years
- All-Time High Comparison
- JAZZ quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- JAZZ quarterly EBITDA is +362.74% above its 3-year low of $108.98M reached on
- Sector Comparison
- JAZZ quarterly EBITDA is higher than 94.77% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $504.30M | +27.6% | +28.3% | +59.0% | +143.4% | |
| Annual EBITDA | $1.45B | – | +4.4% | +7.2% | +38.7% | |
| TTM EBITDA | $1.67B | +7.1% | +30.0% | +43.8% | +67.1% | |
| Price | $244.96 | +6.0% | +110.0% | +75.0% | +72.3% | |
| PE Ratio | 16.89 | – | – | – | -88.8% | |
| Quarterly Revenue | $1.21B | +13.0% | +15.6% | +26.2% | +60.7% | |
| Quarterly EPS | $2.78 | -37.4% | +123.7% | +95.6% | +145.5% | |
| $325.20M | +52.1% | +48.5% | +106.3% | +442.8% | ||
| Quarterly Net Income | $192.80M | -34.2% | +126.8% | +84.6% | +153.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $504.30M | at high | |
| 3Y | $504.30M | at high | |
| 5Y | $504.30M | at high | |
| All | $504.30M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $339.76M | +48.4% | |
| 3Y | $108.98M | +362.7% | |
| 5Y | $108.98M | +362.7% | |
| All | -$111.24M | +553.4% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of JAZZ?
- As of today, JAZZ quarterly EBITDA is $504.30M
- What is JAZZ quarterly EBITDA most recent change?
- JAZZ quarterly EBITDA was up +27.61% on June 30, 2026
- What is 1-year change in JAZZ quarterly EBITDA?
- JAZZ quarterly EBITDA is up +28.33% year-over-year
- How far is JAZZ quarterly EBITDA from its all-time high?
- JAZZ quarterly EBITDA is currently at its all-time high
- How does JAZZ quarterly EBITDA rank versus sector peers?
- JAZZ quarterly EBITDA is higher than 94.77% of companies in Healthcare sector
- When is JAZZ next earnings release?
- The next earnings release for JAZZ is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$1.67B$111.32M+7.13%
Summary
- Current Value
- As of today, JAZZ TTM EBITDA is $1.67B, up +7.13% on
- Historical Performance
- JAZZ TTM EBITDA is up +30.03% year-over-year, up +43.77% over the past 3 years
- All-Time High Comparison
- JAZZ TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- JAZZ TTM EBITDA is +43.77% above its 3-year low of $1.16B reached on an earlier date
- Sector Comparison
- JAZZ TTM EBITDA is higher than 94.58% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.67B | +7.1% | +30.0% | +43.8% | +67.1% | |
| Annual EBITDA | $1.45B | – | +4.4% | +7.2% | +38.7% | |
| Quarterly EBITDA | $504.30M | +27.6% | +28.3% | +59.0% | +143.4% | |
| Price | $244.96 | +6.0% | +110.0% | +75.0% | +72.3% | |
| PE Ratio | 16.89 | – | – | – | -88.8% | |
| TTM Revenue | $4.60B | +3.7% | +12.6% | +22.3% | +75.2% | |
| TTM EPS | $14.50 | +10000.0% | +314.9% | +919.4% | +1435.6% | |
| $955.04M | +12.5% | +55.5% | +72.7% | +49.8% | ||
| TTM Net Income | $940.76M | +3089.8% | +332.4% | +1187.4% | +2242.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.67B | at high | |
| 3Y | $1.67B | at high | |
| 5Y | $1.67B | at high | |
| All | $1.67B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.20B | +39.3% | |
| 3Y | $1.16B | N/A | +43.8% |
| 5Y | $943.46M | +77.3% | |
| All | -$165.94M | +1108.2% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of JAZZ?
- As of today, JAZZ TTM EBITDA is $1.67B
- What is JAZZ TTM EBITDA most recent change?
- JAZZ TTM EBITDA was up +7.13% on June 30, 2026
- What is 1-year change in JAZZ TTM EBITDA?
- JAZZ TTM EBITDA is up +30.03% year-over-year
- How far is JAZZ TTM EBITDA from its all-time high?
- JAZZ TTM EBITDA is currently at its all-time high
- How does JAZZ TTM EBITDA rank versus sector peers?
- JAZZ TTM EBITDA is higher than 94.58% of companies in Healthcare sector
- When is JAZZ next earnings release?
- The next earnings release for JAZZ is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- JAZZ Official Website www.jazzpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1232524/000123252426000013/0001232524-26-000013-index.htm
- JAZZ Profile on Yahoo Finance finance.yahoo.com/quote/JAZZ
- JAZZ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jazz
